Cargando…
Assessing the impact of gestational age of donors on the efficacy of amniotic epithelial cell-derived extracellular vesicles in experimental bronchopulmonary dysplasia
BACKGROUND AND RATIONALE: Extracellular vesicles (EVs) are a potential cell-free regenerative medicine. Human amniotic epithelial cells (hAECs) are a viable source of cell therapy for diseases like bronchopulmonary dysplasia (BPD). However, little is known about the impact of gestational age of the...
Autores principales: | Zhu, Dandan, Krause, Mirja, Yawno, Tamara, Kusuma, Gina D., Schwab, Renate, Barabadi, Mehri, Maleken, Amina S., Chan, Siow T., Hunt, Rod, Greening, David, Wallace, Euan M., Lim, Rebecca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9102678/ https://www.ncbi.nlm.nih.gov/pubmed/35550006 http://dx.doi.org/10.1186/s13287-022-02874-4 |
Ejemplares similares
-
First‐In‐Human Administration of Allogeneic Amnion Cells in Premature Infants With Bronchopulmonary Dysplasia: A Safety Study
por: Lim, Rebecca, et al.
Publicado: (2018) -
Microbial signatures in amniotic fluid at preterm birth and association with bronchopulmonary dysplasia
por: Staude, Birte, et al.
Publicado: (2023) -
Untargeted Metabolomic Analysis of Amniotic Fluid in the Prediction of Preterm Delivery and Bronchopulmonary Dysplasia
por: Baraldi, Eugenio, et al.
Publicado: (2016) -
Two‐year outcomes of infants enrolled in the first‐in‐human study of amnion cells for bronchopulmonary dysplasia
por: Malhotra, Atul, et al.
Publicado: (2019) -
Pulmonary Hemosiderosis in Children with Bronchopulmonary Dysplasia
por: Kurahara, David, et al.
Publicado: (2014)